innoVitro logo — Mechanobiology Assay and Service Provider

innoVitro

Mechanobiology Assay and Service Provider

Founded 2018 Germany Julich, Germany 4 employees Biopharma, Biotechnology

General Information

Company Name innoVitro
Founded Year 2018
Location Germany Julich, Germany
Employees 4
Industries Biopharma, Biotechnology
Social

BounceWatch is an independent company data service, not affiliated with innoVitro. To contact innoVitro, visit innovitro.de.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does innoVitro compare?

A PDF of innoVitro and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting innoVitro soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About innoVitro

innoVitro is a company focused on mechanobiology assay and service provision, with a slogan of "Mechanobiology Assay and Service Provider." Founded in 2018 and headquartered in Germany, innoVitro is a Contract Research Organization (CRO) that specializes in human-based cell analytics. The company's innovative technologies prioritize speed, label-free operations, and real-time analysis, enabling the assessment of functional and structural cellular readouts with precision and high throughput. Their services are tailored to the needs of Biopharma and Biotechnology industries, specifically targeting drug discovery with comprehensive preclinical safety assessments, toxicity evaluations, and efficacy studies. Currently, there is no public information available regarding innoVitro's last investment and investors.

Business keywords: Contract Research Organization, Cell Analytics, Drug Discovery, Preclinical Safety Assessments, Toxicity Evaluations, Efficacy Studies, Human-based Cell Assays, Label-free Technology, Real-time Analysis, Cell Viability, Cell Connectivity, Electrophysiology, Pharmaceutical Industry, Nutritional Industry

No funding data available for innoVitro yet.

innoVitro Alternatives & Competitors

View All Alternatives
innoVitro vs
IBIS Technologies
IBIS Technologies The Netherlands

World leader in multiplex SPR imaging – a groundbreaking technology for detecting and analyzing biom...

6 employees
Analytics, Biopharma
innoVitro vs
CN Bio
CN Bio United Kingdom

Generate human-specific efficacy and safety data with PhysioMimix® microphysiological systems.

Series B
59 employees
Biopharma, Biotechnology
innoVitro vs
Canvax
Canvax Spain

Powerful Solutions to Accelerate your Biologics Manufacturing.

Grant
12 employees
Biopharma, Biotechnology

FAQ About innoVitro

Mechanobiology Assay and Service Provider
innoVitro was founded in 2018.
innoVitro is headquartered in Julich, Germany.
innoVitro operates in Biopharma and Biotechnology. Its work centres on Contract Research Organization, Cell Analytics, Drug Discovery and Preclinical Safety Assessments.
innoVitro has approximately 4 employees.
Top alternatives and competitors to innoVitro include IBIS Technologies, CN Bio, Canvax, IVIM Technology, InterAx Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
innoVitro and IBIS Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for innoVitro, https://bouncewatch.com/company/innovitro, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes